semaglutide and kidney infection lowers UACR in overweight CKD patients Semaglutide: A New Era in

Gastrointestinal side effects caused 5.6% of semaglutide patients to stop their medication entirely, compared to only 2.7% of tirzepatide patients.[1] That's roughly half the dropout rate due to GI issues

These studies provide a clinical perspective that complements the personal anecdotes, offering a holistic view of Ozempic's potential as a transformative agent in weight loss

Mitra, S., De, A

Now, Im terrified that all that progress could be undone and return me to where I started

Vogel JH, Bolling SF, Costello RB, et al

a 2024 study from the University of Birmingham (Abafe et al., published in Environment International) provided the first experimental evidence that toxic chemicals present as additives in microplastics can leach into human sweat and then be absorbed through the skin into the bloodstream